23andMe Holding Operating Expenses 2021-2024 | MEHCQ
23andMe Holding operating expenses from 2021 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
23andMe Holding Annual Operating Expenses
(Millions of US $) |
| 2024 |
$901 |
| 2023 |
$624 |
| 2022 |
$526 |
| 2021 |
$429 |
| 2020 |
$1 |
| 2020 |
$564 |
23andMe Holding Quarterly Operating Expenses
(Millions of US $) |
| 2024-12-31 |
$96 |
| 2024-09-30 |
$105 |
| 2024-06-30 |
$112 |
| 2024-03-31 |
$294 |
| 2023-12-31 |
$308 |
| 2023-09-30 |
$129 |
| 2023-06-30 |
$170 |
| 2023-03-31 |
$162 |
| 2022-12-31 |
$164 |
| 2022-09-30 |
$144 |
| 2022-06-30 |
$154 |
| 2022-03-31 |
$170 |
| 2021-12-31 |
$154 |
| 2021-09-30 |
$102 |
| 2021-06-30 |
$101 |
| 2021-03-31 |
$3 |
| 2020-12-31 |
$101 |
| 2020-09-30 |
$88 |
| 2020-06-30 |
$85 |
| 2020-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.220B |
|
23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition Corp., is headquartered in Sunnyvale, CA.
|
